author-photo

Gero Luschin-Ebengreuth

Medical University of Graz

31

Papers

2791

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (194)
International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases.

2013 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (33)
Multi-Institutional Comparison of Non-sentinel Lymph Node Predictive Tools in Breast Cancer Patients with High Predicted Risk of Further Axillary Metastasis

2013 Pathology & Oncology Research
Show All
- Source
- Cite
- Save
Citations (12)
International Multicenter Tool to Predict the Risk of Nonsentinel Node Metastases in Breast Cancer

2012 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (69)
Iconography : Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

2012
Show All
- Source
- Cite
- Save
Citations (0)
Patients' view of routine follow-up after breast cancer treatment.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

2011 Bone
Show All
- Source
- Cite
- Save
Citations (2)
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

2011 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (378)
S1-2: Long-Term Follow-Up in ABCSG-12: Significantly Improved Overall Survival with Adjuvant Zoledronic Acid in Premenopausal Patients with Endocrine-Receptor–Positive Early Breast Cancer.

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (43)
Mature results from ABCSG-12: Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with endocrine-responsive early breast cancer.

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (35)